Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis
Research output: Contribution to journal › Article › peer-review
Electronic versions
DOI
Keywords
- Adalimumab, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Arthritis, Rheumatoid, Blood Pressure, Endothelium, Vascular, England, Etanercept, Humans, Immunoglobulin G, Inflammation Mediators, Infliximab, Longitudinal Studies, Microvessels, Receptors, Tumor Necrosis Factor, Time Factors, Treatment Outcome, Tumor Necrosis Factor-alpha, Letter, Research Support, Non-U.S. Gov't
| Original language | English |
|---|---|
| Pages (from-to) | 699-702 |
| Number of pages | 4 |
| Journal | Journal of human hypertension |
| Volume | 25 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Nov 2011 |
| Externally published | Yes |